Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Camsirubicin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ph 1b
    Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ph 1b

    01 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/01/2770950/0/en/Monopar-Presents-Data-Showing-Tumor-Reduction-Benefit-of-Camsirubicin-from-Ongoing-Phase-1b-at-the-2023-Connective-Tissue-Oncology-Society-CTOS-Annual-Meeting.html

    GLOBENEWSWIRE
    01 Nov 2023
    Share Share
    Monopar Announces Timeline of Upcoming Q1 2023 Data Events
    Monopar Announces Timeline of Upcoming Q1 2023 Data Events

    26 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/26/2595889/0/en/Monopar-Announces-Projected-Timeline-of-Upcoming-Q1-2023-Data-Events-for-Validive-Camsirubicin-and-MNPR-101-RIT.html

    GLOBENEWSWIRE
    26 Jan 2023
    Share Share
    Monopar Initiates Open-Label Phase 1b Clinical Trial Evaluating Camsirubicin
    Monopar Initiates Open-Label Phase 1b Clinical Trial Evaluating Camsirubicin

    16 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/16/2298363/0/en/Monopar-Initiates-Open-Label-Phase-1b-Clinical-Trial-Evaluating-Camsirubicin-in-Patients-with-Advanced-Soft-Tissue-Sarcoma.html

    GLOBENEWSWIRE
    16 Sep 2021
    Share Share
    Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial
    Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial

    03 Aug 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/monopar-announces-fda-clearance-to-proceed-with-camsirubicin-clinical-trial-targeting-advanced-soft-tissue-sarcoma/

    BIOSPACE
    03 Aug 2021
    Share Share